ArticleFrontiers in medicine2026
Effect of rapid antiretroviral therapy initiation on loss to follow-up, virologic failure, and immunologic failure among people living with HIV under the treat-all policy in China: a retrospective cohort study (2016-2023).
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Since 2016, China has fully implemented the Treat-All policy, which eliminated the CD4 cell count threshold and ensures timely antiretroviral therapy (ART) for all people living with HIV (PLWH). This study aimed to evaluate the impact of rapid ART initiation ( ≤ 7 days post-HIV diagnosis) versus delayed initiation on loss to follow-up (LTFU), virologic failure, and immunologic failure among PLWH. Methods: This study enrolled newly diagnosed, ART-naive adult PLWH in Guizhou Province, China, between 2016 and 2023. Kaplan-Meier analysis was used to examine LTFU across groups. Multivariable Cox regression was employed to evaluate the association between rapid ART initiation and LTFU, and logistic regression with multiple imputation was used to assess 12-month virologic and immunologic outcomes. Results: Among 8163 participants, 2604 (31.9%) initiated ART within 7 days of diagnosis. The rapid ART initiation rate increased from 26.5% in 2016 to 47.0% in 2023. The LTFU rate was comparable between rapid and delayed (≥30 days) initiators (31.2% vs. 32.5%, Discussion: Real-world data indicate that rapid ART initiation does not reduce LTFU risk, but significantly elevates the dual risks of virologic and suboptimal immunologic failure. To achieve clinical benefits when scaling up rapid ART in resource-limited settings, initiation pathways must be paired with individualized, intensified pre-ART counselling and comprehensive adherence support.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.